Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Fluoxymesterone
Drug ID BADD_D00934
Description An anabolic steroid that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women.
Indications and Usage In males, used as replacement therapy in conditions associated with symptoms of deficiency or absence of endogenous testosterone. In females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.
Marketing Status approved; illicit
ATC Code G03BA01
DrugBank ID DB01185
KEGG ID D00327
MeSH ID D005474
PubChem ID 6446
TTD Drug ID D0L2LS
NDC Product Code 64181-0082; 65089-0052
UNII 9JU12S4YFY
Synonyms Fluoxymesterone | Fluoximesteron | Halotestin | Stenox | Android-F | Android F
Chemical Information
Molecular Formula C20H29FO3
CAS Registry Number 76-43-7
SMILES CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C)O)C)O)F
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acne23.02.01.001---
Alopecia23.02.02.001--
Amenorrhoea05.05.01.002; 21.01.02.001--
Anaphylactic shock10.01.07.002; 24.06.02.004---
Anaphylactoid reaction10.01.07.003; 24.06.03.007---
Anxiety19.06.02.002--
Azoospermia21.03.03.001--
Blood calcium13.11.01.041---
Blood chloride13.11.01.042---
Blood cholesterol increased13.12.01.002--
Blood gonadotrophin decreased13.10.03.001---
Blood phosphorus13.11.01.023---
Blood potassium13.11.01.032---
Clitoral engorgement21.08.02.006---
Coagulopathy01.01.02.001---
Coma hepatic09.01.03.005; 17.02.09.002---
Depression19.15.01.001--
Dysphonia17.02.08.004; 19.19.03.002; 22.12.03.006--
Enlarged clitoris05.05.01.004; 21.08.02.001---
Erection increased19.08.04.002; 21.03.01.004---
Fluid retention14.05.06.002; 20.01.02.003---
Gynaecomastia05.05.02.003; 21.05.04.003--
Haemoglobin13.01.05.018---
Headache17.14.01.001--
Hepatic neoplasm09.04.03.001; 16.07.03.001---
Hirsutism05.05.01.005; 23.02.04.001--
Hypersensitivity10.01.03.003--
Jaundice cholestatic09.01.01.005---
Libido decreased19.08.03.001; 21.03.02.005--
Libido increased19.08.03.002; 21.03.02.007--
The 1th Page    1 2    Next   Last    Total 2 Pages